Global Healthcare Trends Will Expand Affordable Generics Amid Risks
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
16 Jul 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
₹1,414.71
38.2% undervalued intrinsic discount20 Aug
₹874.85
1Y
-44.1%7D
0.05%